A multicenter, eight-week treatment, single step titration, open-label study assessing the percentage of subjects achieving low density lipoprotein cholesterol target with atorvastatin starting doses of 10 mg, 20 mg, 40 mg, and 80 mg (Latin American atorvastatin ATGOAL study)

Trial Profile

A multicenter, eight-week treatment, single step titration, open-label study assessing the percentage of subjects achieving low density lipoprotein cholesterol target with atorvastatin starting doses of 10 mg, 20 mg, 40 mg, and 80 mg (Latin American atorvastatin ATGOAL study)

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Apr 2008

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Hypercholesterolaemia
  • Focus Therapeutic Use
  • Acronyms LA-ATGOAL
  • Sponsors Pfizer
  • Most Recent Events

    • 14 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top